T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.17% |
| 4 | Financials | 10.75% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Telephone and Data Systems
TDS
$4.03B
| $19.9M | ﹤0.01% |
1,053,608
-1,441,194
| -58% | -$27.9M |
|
1227
Hain Celestial
HAIN
$53.9M
| $19.8M | ﹤0.01% |
576,676
-359,808
| -38% | -$13.1M |
|
1228
Aaon
AAON
$7.23B
| $19.2M | ﹤0.01% |
516,066
-43,199
| -8% | -$1.76M |
|
|
ZIMV
1229
DELISTED
ZimVie
ZIMV
| $19.1M | ﹤0.01% |
+838,444
| New | +$19.7M |
|
1230
NeoGenomics
NEO
$2.11B
| $19M | ﹤0.01% |
1,566,937
+16,655
| +1% | +$350K |
|
1231
Chemed
CHE
$7.02B
| $19M | ﹤0.01% |
37,451
+99
| +0.3% | +$47.5K |
|
1232
Ubiquiti
UI
$35B
| $18.9M | ﹤0.01% |
65,057
-51,158
| -44% | -$13.8M |
|
1233
Abercrombie & Fitch
ANF
$4.84B
| $18.8M | ﹤0.01% |
589,050
-148,902
| -20% | -$5.16M |
|
1234
Everest Group
EG
$13.9B
| $18.7M | ﹤0.01% |
62,107
+87
| +0.1% | +$25K |
|
1235
Qorvo
QRVO
$8.67B
| $18.7M | ﹤0.01% |
150,796
-14,882
| -9% | -$2.01M |
|
1236
Viatris
VTRS
$18.4B
| $18.7M | ﹤0.01% |
1,714,878
-97,906
| -5% | -$1.29M |
|
1237
Cheniere Energy
LNG
$55B
| $18.6M | ﹤0.01% |
134,314
+15,007
| +13% | +$1.82M |
|
1238
STRATTEC Security
STRT
$338M
| $18.5M | ﹤0.01% |
496,243
-3,154
| -0.6% | -$122K |
|
1239
Rollins
ROL
$17.4B
| $18.5M | ﹤0.01% |
527,018
-33,705
| -6% | -$1.09M |
|
|
RETA
1240
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $18.4M | ﹤0.01% |
562,749
-403,262
| -42% | -$12M |
|
1241
Alarm.com
ALRM
$2.74B
| $18.4M | ﹤0.01% |
277,191
+2,049
| +0.7% | +$145K |
|
1242
W.R. Berkley
WRB
$25.9B
| $18.2M | ﹤0.01% |
410,327
-28,079
| -6% | -$1.12M |
|
1243
Essential Utilities
WTRG
$11.3B
| $18.1M | ﹤0.01% |
354,463
-28,624
| -7% | -$1.38M |
|
1244
LKQ Corp
LKQ
$6.25B
| $18.1M | ﹤0.01% |
398,726
-21,204
| -5% | -$1.08M |
|
|
IAS
1245
DELISTED
Integral Ad Science
IAS
| $18.1M | ﹤0.01% |
1,311,069
+133,769
| +11% | +$2.28M |
|
1246
Petrobras
PBR
$115B
| $18.1M | ﹤0.01% |
1,221,683
-132,700
| -10% | -$1.78M |
|
1247
Organon & Co
OGN
$3.6B
| $18M | ﹤0.01% |
515,238
-23,347
| -4% | -$798K |
|
1248
Haemonetics
HAE
$4.11B
| $18M | ﹤0.01% |
284,353
-40,007
| -12% | -$2.18M |
|
|
CCF
1249
DELISTED
Chase Corporation
CCF
| $17.9M | ﹤0.01% |
206,377
-55,955
| -21% | -$5.19M |
|
1250
SOPHiA GENETICS
SOPH
$649M
| $17.9M | ﹤0.01% |
2,319,740
-62,564
| -3% | -$703K |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.